TRI - TrivarX Limited

[greggles]

Hey greg, I think the agreement is just for Compass staff to be crash test dummies for the ilumen app. I've had a look back through their history and what they're trying to do and I question the efficacy of their product. Testing mental health disorders through heart rate alone doesn't pass the sniff test to me. But, with Michael Phelps on the board they should all be pretty good swimmers I guess.

Yeah, I'm pretty skeptical as well and their chart is simply horrific. I note they're down to 2.1c this morning from 2.6c when I posted yesterday so I reckon that yesterday's brief share price jump enabled some punters to make a quick exit.

That's the thing with stocks with charts like this one, any share price increase is going to be met with waves of selling as people take the opportunity to exit the stock.

Think this one will be back under 2c shortly.

 

[greggles]

Think this one will be back under 2c shortly.

Well back under 2c it went, bottoming out at 1.1c a couple of days ago. But MEB is off and running again today after the company announced that it has signed a second commercial agreement with Compass Group PLC for its corporate health product, ilumen™. This agreement relates to a second pilot in their Offshore and Remote Division.

Again, there is no mention of possible future revenue so it all seems a little pie-in-the-sky but nonetheless MEB is up a whopping 141.7% to 2.9c today after the announcement. Volume is strong with over 60 million shares traded.

 

[Tumbarumba]

Down to 1.2c on back of recent 1c raise (with 3c options attached) raising $4m with Mkt Cap only $3.5m.
And with major Board restructure and 3 new key appointments signalling a new direction for their health technology products it only needs a minor positive announcement to take off. Profit taking from SPP must be about over too. My tip in September comp.

 

[Tumbarumba]

I have been misled by Yahoo, Market Cap is substantially more than$3.5m. Latest “substantial holder” announcement quotes 25m
Shareholding as being 2.51% of shares on issue making Market Cap around $13m which is much more than cash backing not less

 

[Tumbarumba]

The annual 2019 report just released makes bleak reading. The only reason I tip it is that the major recent reorganisation has introduced talented people whose remuneration depends on share price appreciation and from a base of 1.2c, the % gain could be good. Disclosure, I do not own and am unlikely ever to, which is another reason it may do well.

 

[System]

On October 16th, 2023, Medibio Limited (MEB) changed its name and ASX code to TrivarX Limited (TRI).

 

[Country Lad]

Maybe I need one of these gadgets for my depressive episode every time I see one of these minnows jump without me. Here is another one but I'm afraid it is difficult to get serious abbot or spend time on, a 1.5 cent share.

Ground breaking advancement of depression screening tool
significantly broadens patient reach and market opportunities
Newly developed algorithm achieves 87% sensitivity and 67% specificity in identifying current
Major Depressive Episode (cMDE) using only a single lead ECG
Highlights:
• Completion of R&D program culminates in the advancement of MEB-001 – designed for
current Major Depressive Episode (cMDE) screening
• New algorithm uses only heart rate and heart rate variability as biomarkers to accurately
conduct sleep staging and screen for cMDE
• Allows TrivarX to unlock large new addressable market opportunities outside of sleep
centres including cardiology monitoring, sports and performance, military, treatment
monitoring and consumer wearables
• Initial testing has provided promising results – new algorithm was tested on data from 295
phase 2 trial data subsets and delivered:
o Sensitivity: 87% (95% CI 74-95%)
o Specificity: 67% (95% CI 62-73%)
• Additional work underway to advance potential sponsored clinical trials utilising new
algorithm, as well as testing and licensing opportunities
• Provisional patent application filed to strengthen competitive moat.